Eylem Öztürk

716 total citations
12 papers, 554 citations indexed

About

Eylem Öztürk is a scholar working on Pharmaceutical Science, Rehabilitation and Biomaterials. According to data from OpenAlex, Eylem Öztürk has authored 12 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Rehabilitation and 3 papers in Biomaterials. Recurrent topics in Eylem Öztürk's work include Wound Healing and Treatments (3 papers), Advanced Drug Delivery Systems (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Eylem Öztürk is often cited by papers focused on Wound Healing and Treatments (3 papers), Advanced Drug Delivery Systems (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Eylem Öztürk collaborates with scholars based in Türkiye, United States and Russia. Eylem Öztürk's co-authors include Emir Baki Denkbaş, Cengiz Birlikseven, Ebru Kılıçay, Canan Ağalar, Kaan Keçeci, Ángela Sanguino, Zhenghong Peng, Erdal Uğuzdoğan, Alejandro Crespo and Ariel Fernández and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Journal of Hazardous Materials.

In The Last Decade

Eylem Öztürk

12 papers receiving 544 citations

Peers

Eylem Öztürk

BIOMA

MB

OC

BE

MC

Vahid Rahimkhoei Iran

Qiming Xu China

Yuzhi Mu China

Thomas Chandy India

Simiao Yu China

Zhihao Guo China

Mehmet Ali Onur Türkiye

M. Dolores Blanco Spain

Maoquan Li China

Vahid Rahimkhoei Iran

Eylem Öztürk

173 ×0.9

BIOMA

60 ×0.5

MB

49 ×0.5

OC

145 ×1.4

BE

121 ×1.9

MC

Citations per year, relative to Eylem Öztürk Eylem Öztürk (= 1×) peers Vahid Rahimkhoei

Countries citing papers authored by Eylem Öztürk

Since Specialization

Citations

This map shows the geographic impact of Eylem Öztürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eylem Öztürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eylem Öztürk more than expected).

Fields of papers citing papers by Eylem Öztürk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eylem Öztürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eylem Öztürk. The network helps show where Eylem Öztürk may publish in the future.

Co-authorship network of co-authors of Eylem Öztürk

This figure shows the co-authorship network connecting the top 25 collaborators of Eylem Öztürk. A scholar is included among the top collaborators of Eylem Öztürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eylem Öztürk. Eylem Öztürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Uğuzdoğan, Erdal, et al.. (2008). Preparation and characterization of polyethyleneglycolmethacrylate (PEGMA)-co-vinylimidazole (VI) microspheres to use in heavy metal removal. Journal of Hazardous Materials. 162(2-3). 1073–1080. 43 indexed citations

2.

Mangala, Lingegowda S., Hee Dong Han, Chunhua Lü, et al.. (2008). In vivo vascular and tumor cell gene silencing with chitosan nanoparticles in ovarian carcinoma. 68. 5613–5613. 2 indexed citations

3.

Fernández, Ariel, Ángela Sanguino, Zhenghong Peng, et al.. (2007). Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target. Cancer Research. 67(9). 4028–4033. 32 indexed citations

4.

Fernández, Ariel, Ángela Sanguino, Zhenghong Peng, et al.. (2007). An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. Journal of Clinical Investigation. 117(12). 4044–4054. 107 indexed citations

5.

Kılıç, Dilek, et al.. (2007). ANTIMICROBIAL ACTIVITY OF CEFAZOLIN‐IMPREGNATED MESH GRAFTS. ANZ Journal of Surgery. 77(4). 256–260. 19 indexed citations

6.

Ağalar, Canan, et al.. (2007). Inhibition of Staphylococcus Epidermidis Colonization with Fusidic Acid-Impregnated Catheters. Journal of Bioactive and Compatible Polymers. 22(2). 160–173. 4 indexed citations

7.

Öztürk, Eylem, Canan Ağalar, Kaan Keçeci, & Emir Baki Denkbaş. (2006). Preparation and characterization of ciprofloxacin‐loaded alginate/chitosan sponge as a wound dressing material. Journal of Applied Polymer Science. 101(3). 1602–1609. 49 indexed citations

8.

Öztürk, Eylem, et al.. (2005). Mitomycin-C-loaded Alginate Carriers for Bladder Cancer Chemotherapy: In Vivo Studies. Journal of Bioactive and Compatible Polymers. 20(2). 197–208. 6 indexed citations

9.

Öztürk, Eylem, et al.. (2004). Norfloxacin-loaded Chitosan Sponges as Wound Dressing Material. Journal of Biomaterials Applications. 18(4). 291–303. 57 indexed citations

10.

Öztürk, Eylem, Muzaffer Eroğlu, Nalan Özdemir, & Emir Baki Denkbaş. (2004). Bioadhesive Drug Carriers for Postoperative Chemotherapy in Bladder Cancer. Advances in experimental medicine and biology. 553. 231–242. 5 indexed citations

11.

Denkbaş, Emir Baki, et al.. (2003). EGF Loaded Chitosan Sponges as Wound Dressing Material. Journal of Bioactive and Compatible Polymers. 18(3). 177–190. 11 indexed citations

12.

Denkbaş, Emir Baki, Ebru Kılıçay, Cengiz Birlikseven, & Eylem Öztürk. (2002). Magnetic chitosan microspheres: preparation and characterization. Reactive and Functional Polymers. 50(3). 225–232. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact